Press & media

MYoroface, the Swedish healthtech company behind the IQoro, has been named one of the fastest growing companies in Europe. The award comes from the annual FT 1000 report developed by The Financial Times, which ranks European companies that have achieved the highest growth in recent years. In the UK, around 13 million people suffer from […]

IQoro on prescription

IQoro is available on prescription on the NHS from 1st May 2022. This means your GP can prescribe IQoro as a treatment, if they find it to be a suitable treatment for you. How to get IQoro on prescription IQoro is still a new device to many health professionals. Some might have heard of it briefly […]

IQoro achieves prescription status in the UK

From 1st May 2022 IQoro is listed as a device that a GP can prescribe in the UK. The GP’s will do this where they judge that IQoro is a suitable treatment for their patient’s condition.

Read all press releases